Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 8/20 | 0.62 |
| ▸ | NAALAD2 | Q9Y3Q0 | 3/20 | 0.62 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.62 |
| ▸ | GNPAT | O15228 | 1/20 | 0.49 |
| ▸ | GGH | Q92820 | 1/20 | 0.49 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.47 |
| ▸ | FNTA | P49354 | 2/20 | 0.47 |
| ▸ | FNTB | P49356 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28385118 | 1.00 | FOLH1 (0.62) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL10523153 | 1.00 | FOLH1 (0.62) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL14729416 | 0.88 | FOLH1 (0.72) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL14719913 | 0.88 | FOLH1 (0.72) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL11961967 | 0.87 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL4572551 | 0.86 | FOLH1 (0.69) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL72024 | 0.85 | FOLH1 (0.52) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL14310838 | 0.84 | FOLH1 (0.72) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL19718595 | 0.83 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL18082026 | 0.83 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLAGNPATGGH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113960200-A | Application of metabolic marker in diagnosis of ADHD (ADHD-associated tic disorder) of children | 首都医科大学附属北京儿童医院 | 2022-01-21 | — | — | CN | claimed |
| CN-113747927-A | Prostate Specific Membrane Antigen (PSMA) ligands comprising an amylase cleavable linker | 德国癌症研究中心 | 2021-12-03 | — | — | CN | disclosed |
| CN-113710286-A | Prostate Specific Membrane Antigen (PSMA) ligands with improved tissue specificity | 海德堡鲁普雷希特卡尔斯大学 | 2021-11-26 | — | — | CN | disclosed |
| CN-111362971-B | PSMA (patterned beam mosaic Virus inhibitor) -targeted bis-benzothiadiazole compound as well as preparation method and application thereof | 北京师范大学 | 2021-02-09 | — | — | CN | disclosed |
| CN-111362971-A | PSMA (patterned beam mosaic Virus inhibitor) -targeted bis-benzothiadiazole compound as well as preparation method and application thereof | 北京师范大学 | 2020-07-03 | — | — | CN | disclosed |
| CN-111032678-A | Bicyclic peptide ligands with detectable moieties and uses thereof | 拜西克尔德有限公司 | 2020-04-17 | — | — | CN | disclosed |